Global – October 27, 2026 -- The Truveta Genome Project aims to build the largest and most diverse de-identified database of exome-wide genomic data linked to high-fidelity clinical data ever assembled, according to a statement from a Truveta executive who joined the company earlier this year.
Health systems founded Truveta during the pandemic to speed up learning
Leading health systems created Truveta during the global pandemic around one premise: healthcare should learn faster. Patient experiences, clinical insights and research findings are meant to feed a shared resource rather than stay siloed within single institutions.
Genome Project links genomic data with longitudinal clinical records
Participating health systems connect genomic information with longitudinal clinical data. The combined dataset is designed to let researchers examine the relationship between biology, disease, treatments and outcomes, and to explain not only what happened to a patient but why.
The executive argues that evidence remains fragmented and insights move too slowly, and that improving care should not always depend on waiting for the next prospective clinical trial.
Imaging data is the next layer in Truveta's multi-source model
Truveta describes three complementary data types. Clinical data show a patient's journey, genomic data explain biology, and imaging data add a view of disease progression and treatment response. Combined, the sources are intended to support research and evidence generation.
The statement gives no participant count, dataset size, timeline or funding figures for the project.